GMT Capital’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
GMT Capital's NAGE Position: Q3 2026 in Review
GMT Capital opened a new position in Niagen Bioscience (NAGE) in Q3 2026: 296,905 shares worth $867K. The stake represents 0.04% of the portfolio and ranks #69 among its holdings. This is a return to the name: GMT Capital previously reported a position in NAGE as recently as Q3 2023.
GMT Capital first reported a position in NAGE in Q1 2023 and has held it in 4 quarters since. 123 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.
- GMT Capital held 296,905 shares of Niagen Bioscience worth $867K as of Q3 2026.
- Niagen Bioscience was a new GMT Capital position in Q3 2026.
- Niagen Bioscience made up 0.04% of GMT Capital's portfolio in Q3 2026, its #69 holding.
- GMT Capital first reported a position in Niagen Bioscience in Q1 2023 and has held it in 4 quarters since.
- 123 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.
Based on GMT Capital's 13F filing for Q3 2026, filed 16 Nov 2026.